In the article titled “HDAC and HMT Inhibitors in Combination with Conventional Therapy: A Novel Treatment Option for Acute Promyelocytic Leukemia” [1], the last author was mistakenly linked to the second affiliation instead of the first. The gene discussed is HDAC9; the disease is acute promyelocytic leukemia.